MicroRNAs: New Therapeutic Targets for Familial Hypercholesterolemia?

por Momtazi, Amir Abbas, Banach, Maciej, Pirro, Matteo, Stein, Evan A., Sahebkar, Amirhossein
Publicado 2017

Safety and tolerability of dalcetrapib (RO4607381/JTT-705): results from a 48-week trial

por Stein, Evan A., Roth, Eli M., Rhyne, James M., Burgess, Tracy, Kallend, David, Robinson, Jennifer G.
Publicado 2010

Adverse effects of statin therapy: perception vs. the evidence – focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract

por Mach, François, Ray, Kausik K, Wiklund, Olov, Corsini, Alberto, Catapano, Alberico L, Bruckert, Eric, De Backer, Guy, Hegele, Robert A, Hovingh, G Kees, Jacobson, Terry A, Krauss, Ronald M, Laufs, Ulrich, Leiter, Lawrence A, März, Winfried, Nordestgaard, Børge G, Raal, Frederick J, Roden, Michael, Santos, Raul D, Stein, Evan A, Stroes, Erik S, Thompson, Paul D, Tokgözoğlu, Lale, Vladutiu, Georgirene D, Gencer, Baris, Stock, Jane K, Ginsberg, Henry N, Chapman, M John
Publicado 2018